Nuclear medicine imaging offers the possibility to study in vivo different aspects of inflammatory process by the use of radio-labeled molecules that bind to specific receptor targets on cells and tissues. This noninvasive technique, combined with pathogens engineered to express luciferase, allows quantification in the same animal of the spatial and temporal progression of the infection and identification of animal-to-animal variations in pathogen replication and dissemination. One strategy to use optical imaging in living animals is the use of luciferase reporter genes as internal sources of light called bioluminescence imaging (BLI). This enables real-time noninvasive imaging of infections and gene expression in living organisms. Nuclear medicine imaging is characterized by the use of radio pharmaceuticals (radiolabeled probes) that, administered in pico- and nanomolar amounts. These probes can also be used for early diagnosis of diseases, in susceptible subjects, for detection of disease relapse and radio-guided surgery.

Molecular Imaging of Inflammation/Infection: Nuclear Medicine and Optical Imaging Agents and Methods / Signore, Alberto; S. J., Mather; G., Piaggio; G., Malviya; R. A., Dierckx. - In: CHEMICAL REVIEWS. - ISSN 0009-2665. - STAMPA. - 110:5(2010), pp. 3112-3145. [10.1021/cr900351r]

Molecular Imaging of Inflammation/Infection: Nuclear Medicine and Optical Imaging Agents and Methods

SIGNORE, Alberto;
2010

Abstract

Nuclear medicine imaging offers the possibility to study in vivo different aspects of inflammatory process by the use of radio-labeled molecules that bind to specific receptor targets on cells and tissues. This noninvasive technique, combined with pathogens engineered to express luciferase, allows quantification in the same animal of the spatial and temporal progression of the infection and identification of animal-to-animal variations in pathogen replication and dissemination. One strategy to use optical imaging in living animals is the use of luciferase reporter genes as internal sources of light called bioluminescence imaging (BLI). This enables real-time noninvasive imaging of infections and gene expression in living organisms. Nuclear medicine imaging is characterized by the use of radio pharmaceuticals (radiolabeled probes) that, administered in pico- and nanomolar amounts. These probes can also be used for early diagnosis of diseases, in susceptible subjects, for detection of disease relapse and radio-guided surgery.
2010
01 Pubblicazione su rivista::01a Articolo in rivista
Molecular Imaging of Inflammation/Infection: Nuclear Medicine and Optical Imaging Agents and Methods / Signore, Alberto; S. J., Mather; G., Piaggio; G., Malviya; R. A., Dierckx. - In: CHEMICAL REVIEWS. - ISSN 0009-2665. - STAMPA. - 110:5(2010), pp. 3112-3145. [10.1021/cr900351r]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/122412
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 120
  • ???jsp.display-item.citation.isi??? 106
social impact